Immunotherapy of cancer
Immunotherapy of cancer: Invited Discussant 1144PD, 1145PD and 1146PD
Date
11 Sep 2017Session
Immunotherapy of cancerPresenters
Fiona ThistlethwaiteAuthors
F. ThistlethwaiteAuthor affiliations
- Medical Oncology, The Christie NHS Foundation Trust, M20 4BX - Manchester/GB
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Immunotherapy of cancer: Invited Discussant 1147PD and 1148PD
Presenter: John Haanen
Session: Immunotherapy of cancer
Resources:
Slides
Webcast
Invited Discussant 1138PD, 1139Pd and 1140PD
Presenter: Christian Blank
Session: Immunotherapy of cancer
Resources:
Slides
Webcast
Immunotherapy of cancer: Invited Discussant 1141PD, 1142PD and 1143PD
Presenter: Paul Nathan
Session: Immunotherapy of cancer
Resources:
Slides
Webcast
1273 - Phase III randomized controlled trial of adjuvant chemoimmunotherapy in patients with resected primary lung cancer
Presenter: Hideki Kimura
Session: Immunotherapy of cancer
Resources:
Abstract
1719 - Phase 1b/2 Study (SCORES) Assessing Safety, Tolerability, and Preliminary Anti-tumor Activity of Durvalumab Plus AZD9150 or AZD5069 in Patients With Advanced Solid Malignancies and Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Presenter: Ezra Cohen
Session: Immunotherapy of cancer
Resources:
Abstract
Slides
Webcast
2757 - Nivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer
Presenter: Bonnie Glisson
Session: Immunotherapy of cancer
Resources:
Abstract
Slides
Webcast
5493 - Interim Analysis of the Phase 3 ADAPT Trial Evaluating Rocapuldencel-T (AGS-003), an Individualized Immunotherapy for the Treatment of Newly-Diagnosed Patients with Metastatic Renal Cell Carcinoma (mRCC)
Presenter: Robert Figlin
Session: Immunotherapy of cancer
Resources:
Abstract
Slides
Webcast
Immunotherapy of cancer: Invited Discussant 1144O and 1135O
Presenter: Thomas Powles
Session: Immunotherapy of cancer
Resources:
Slides
Webcast
Invited Discussant 1136O and 1137O
Presenter: Helen Gogas
Session: Immunotherapy of cancer